{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:11:31Z","timestamp":1788768691865,"version":"build-2803163510"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12015-026-11198-2","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:44:06Z","timestamp":1784954646000},"page":"3152-3171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanotechnology-enabled precision targeting of lung cancer stem cells: Recent developments and therapeutic implications"],"prefix":"10.1007","volume":"22","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-933X","authenticated-orcid":false,"given":"Ming-Fei","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"11198_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025). Cancer statistics, 2025. CA: A Cancer Journal for Clinicians, 75, 10\u201345.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"11198_CR2","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","volume":"28","author":"MB Schabath","year":"2019","unstructured":"Schabath, M. B., & Cote, M. L. (2019). Cancer progress and priorities: Lung cancer. Cancer Epidemiology Biomarkers & Prevention, 28, 1563\u20131579.","journal-title":"Cancer Epidemiology Biomarkers & Prevention"},{"key":"11198_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","volume":"383","author":"N Howlader","year":"2020","unstructured":"Howlader, N., et al. (2020). The effect of advances in lung-cancer t reatment on p opulation m ortality. New England Journal of Medicine, 383, 640\u2013649.","journal-title":"New England Journal of Medicine"},{"key":"11198_CR4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E., & Clevers, H. (2017). Cancer stem cells revisited. Nature Medicine, 23, 1124\u20131134.","journal-title":"Nature Medicine"},{"key":"11198_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2012.08.014","volume":"338","author":"A Lundin","year":"2013","unstructured":"Lundin, A., & Driscoll, B. (2013). Lung cancer stem cells: Progress and prospects. Cancer Letters, 338, 89\u201393.","journal-title":"Cancer Letters"},{"key":"11198_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12, 31\u201346.","journal-title":"Cancer Discovery"},{"key":"11198_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","volume":"22","author":"H Jin","year":"2023","unstructured":"Jin, H., Wang, L., & Bernards, R. (2023). Rational combinations of targeted cancer therapies: Background, advances and challenges. Nature Reviews Drug Discovery, 22, 213\u2013234.","journal-title":"Nature Reviews Drug Discovery"},{"key":"11198_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017). Cancer nanomedicine: progress, challenges and opportunities. Nature Reviews Cancer, 17, 20\u201337.","journal-title":"Nature Reviews Cancer"},{"key":"11198_CR9","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/s41563-021-01047-7","volume":"20","author":"I de L\u00e1zaro","year":"2021","unstructured":"de L\u00e1zaro, I., & Mooney, D. J. (2021). Obstacles and opportunities in a forward vision for cancer nanomedicine. Nature Materials, 20, 1469\u20131479.","journal-title":"Nature Materials"},{"key":"11198_CR10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature Medicine, 19, 1423\u20131437.","journal-title":"Nature Medicine"},{"key":"11198_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D., & Coussens, L. M. (2012). Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell, 21, 309\u2013322","journal-title":"Cancer Cell"},{"key":"11198_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E., & Joyce, J. A. (2023). The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell, 41, 374\u2013403.","journal-title":"Cancer Cell"},{"key":"11198_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1158\/2159-8290.CD-15-0893","volume":"6","author":"R Rupaimoole","year":"2016","unstructured":"Rupaimoole, R., Calin, G. A., Lopez-Berestein, G., & Sood, A. K. (2016). miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discovery, 6, 235\u2013246.","journal-title":"Cancer Discovery"},{"key":"11198_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12943-022-01682-x","volume":"21","author":"P Nallasamy","year":"2022","unstructured":"Nallasamy, P., et al. (2022). Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. Molecular Cancer, 21, 225.","journal-title":"Molecular Cancer"},{"key":"11198_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2020","unstructured":"Biffi, G., & Tuveson, D. A. (2020). Diversity and biology of cancer-associated fibroblasts. Physiological Reviews, 101, 147\u2013176.","journal-title":"Physiological Reviews"},{"key":"11198_CR16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. (2016). The biology and function of fibroblasts in cancer. Nature Reviews Cancer, 16, 582\u2013598.","journal-title":"Nature Reviews Cancer"},{"key":"11198_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2021.05.009","volume":"514","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Jiang, H., Zhu, L., Li, J., & Ma, S. (2021). Cancer-associated fibroblasts in non-small cell lung cancer: Recent advances and future perspectives. Cancer Letters, 514, 38\u201347.","journal-title":"Cancer Letters"},{"key":"11198_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","volume":"172","author":"S Su","year":"2018","unstructured":"Su, S., et al. (2018). CD10\u2009+\u2009GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell, 172, 841\u2013856.e816","journal-title":"Cell"},{"key":"11198_CR19","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1038\/ncomms4472","volume":"5","author":"WJ Chen","year":"2014","unstructured":"Chen, W. J., et al. (2014). Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nature Communications, 5, 3472.","journal-title":"Nature Communications"},{"key":"11198_CR20","doi-asserted-by":"crossref","unstructured":"Nallasamy, P., et al. (2021). Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1-CD44 Axis. Gastroenterology, 161, 1998\u20132013.e1997.","DOI":"10.1053\/j.gastro.2021.08.023"},{"key":"11198_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2022.07.076","volume":"163","author":"J Datta","year":"2022","unstructured":"Datta, J., et al. (2022). Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy resistance in pancreatic cancer. Gastroenterology, 163, 1593\u20131612.","journal-title":"Gastroenterology"},{"key":"11198_CR22","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma, Z., et al. (2022). Interferon-dependent SLC14A1+\u2009cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell, 40, 1550\u20131565.e1557.","journal-title":"Cancer Cell"},{"key":"11198_CR23","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","volume":"83","author":"J Zhuang","year":"2023","unstructured":"Zhuang, J., et al. (2023). Cancer-a Associated fibroblast\u2013derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance. Cancer Research, 83, 1611\u20131627.","journal-title":"Cancer Research"},{"key":"11198_CR24","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1111\/cas.14521","volume":"111","author":"Y Oya","year":"2020","unstructured":"Oya, Y., Hayakawa, Y., & Koike, K. (2020). Tumor microenvironment in gastric cancers. Cancer Science, 111, 2696\u20132707.","journal-title":"Cancer Science"},{"key":"11198_CR25","first-page":"28","volume":"75","author":"Y Gao","year":"2021","unstructured":"Gao, Y., et al. (2021). CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5\u2010lipoxygenase. Hepatology, 75, 28\u201342.","journal-title":"Hepatology"},{"key":"11198_CR26","doi-asserted-by":"publisher","first-page":"151491","DOI":"10.1016\/j.ijmm.2021.151491","volume":"311","author":"I Stolzer","year":"2021","unstructured":"Stolzer, I., Ruder, B., Neurath, M. F., & G\u00fcnther, C. (2021). Interferons at the crossroad of cell death pathways during gastrointestinal inflammation and infection. International Journal of Medical Microbiology, 311, 151491.","journal-title":"International Journal of Medical Microbiology"},{"key":"11198_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/jir.2022.0193","volume":"43","author":"K Mohammad","year":"2023","unstructured":"Mohammad, K., et al. (2023). The role of interferons in long covid infection. Journal of Interferon & Cytokine Research, 43, 65\u201376.","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"11198_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imbio.2015.07.012","volume":"222","author":"J Pahl","year":"2017","unstructured":"Pahl, J., & Cerwenka, A. (2017). Tricking the balance: NK cells in anti-cancer immunity. Immunobiology, 222, 11\u201320.","journal-title":"Immunobiology"},{"key":"11198_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.yexcr.2014.03.020","volume":"324","author":"Y Zhu","year":"2014","unstructured":"Zhu, Y., et al. (2014). Influence of interferon-\u03b1 on the expression of the cancer stem cell markers in pancreatic carcinoma cells. Experimental Cell Research, 324, 146\u2013156.","journal-title":"Experimental Cell Research"},{"key":"11198_CR30","doi-asserted-by":"crossref","unstructured":"Secombes, C. J., & Zou, J. (2017). Evolution of Interferons and Interferon Receptors. Frontiers in Immunology, 8, 209.","DOI":"10.3389\/fimmu.2017.00209"},{"key":"11198_CR31","doi-asserted-by":"crossref","unstructured":"Song, M., et al. (2019) Low-dose IFN\u03b3 induces tumor cell ste mness in tumor microenvironment of non\u2013small cell lung cancer. Cancer Research, 79, 3737-3748.","DOI":"10.1158\/0008-5472.CAN-19-0596"},{"key":"11198_CR32","doi-asserted-by":"crossref","unstructured":"Wang, Y.et al. (2024) Clinical prognostic significance of xeroderma pigmentosum group C and IFN\u2013\u03b3 in non\u2013small cell lung cancer. Oncology Letters, 27, 259.","DOI":"10.3892\/ol.2024.14392"},{"key":"11198_CR33","doi-asserted-by":"crossref","unstructured":"Kaur, K., Celis, A. P., & Jewett, A. (2025). Natural killer cell-secreted IFN-\u03b3 and TNF-\u03b1 mediated differentiation in lung stem-like tumors, leading to the susceptibility of the tumors to chemotherapeutic drugs. Cells, 14, 90.","DOI":"10.3390\/cells14020090"},{"key":"11198_CR34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1158\/2326-6066.CIR-17-0655","volume":"6","author":"N Khosravi","year":"2018","unstructured":"Khosravi, N., et al. (2018). IL22 promotes Kras-mutant lung cancer by induction of a protumor immune response and protection of stemness properties. Cancer Immunology Research, 6, 788\u2013797.","journal-title":"Cancer Immunology Research"},{"key":"11198_CR35","doi-asserted-by":"publisher","first-page":"11573","DOI":"10.1038\/s41598-018-29947-w","volume":"8","author":"CFD Rodrigues","year":"2018","unstructured":"Rodrigues, C. F. D., et al. (2018). Stroma-derived IL-6, G-CSF and activin-A mediated dedifferentiation of lung carcinoma cells into cancer stem cells. Scientific Reports, 8, 11573.","journal-title":"Scientific Reports"},{"key":"11198_CR36","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/ijc.32151","volume":"145","author":"L Yang","year":"2019","unstructured":"Yang, L., et al. (2019). IL-10 derived from M2 macrophage promotes cancer stemness via JAK1\/STAT1\/NF-\u03baB\/Notch1 pathway in non-small cell lung cancer. International Journal of Cancer, 145, 1099\u20131110.","journal-title":"International Journal of Cancer"},{"key":"11198_CR37","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.tcb.2023.03.008","volume":"33","author":"J Liu","year":"2023","unstructured":"Liu, J., & Cao, X. (2023). Glucose metabolism of TAMs in tumor chemoresistance and metastasis. Trends in Cell Biology, 33, 967\u2013978.","journal-title":"Trends in Cell Biology"},{"key":"11198_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale, I., Manic, G., Coussens, L. M., Kroemer, G., & Galluzzi, L. (2019). Macrophages and metabolism in the tumor microenvironment. Cell Metabolism, 30, 36\u201350.","journal-title":"Cell Metabolism"},{"key":"11198_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang, X., Wang, J., Lu, D., & Xu, X. (2021). Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduction and Targeted Therapy, 6, 75.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"11198_CR40","doi-asserted-by":"crossref","unstructured":"Zhang, X., Zhu, M., Hong, Z., & Chen, C. (2021). Co-culturing polarized M2 Thp-1-derived macrophages enhance stemness of lung adenocarcinoma A549 cells. Annals of Translational Medicine. 9, 709.","DOI":"10.21037\/atm-21-1256"},{"key":"11198_CR41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13045-020-00887-1","volume":"13","author":"CS Lu","year":"2020","unstructured":"Lu, C. S., et al. (2020). Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer. Journal of Hematology & Oncology, 13, 62.","journal-title":"Journal of Hematology & Oncology"},{"key":"11198_CR42","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1038\/s41388-018-0411-0","volume":"37","author":"CH Lu","year":"2018","unstructured":"Lu, C. H., et al. (2018). USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2\/TRAF3 complex formation. Oncogene, 37, 6327\u20136340.","journal-title":"Oncogene"},{"key":"11198_CR43","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/cac2.12345","volume":"42","author":"K Cheng","year":"2022","unstructured":"Cheng, K., et al. (2022). Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Communications, 42, 1112\u20131140.","journal-title":"Cancer Communications"},{"key":"11198_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12964-022-00888-2","volume":"20","author":"X Chen","year":"2022","unstructured":"Chen, X., et al. (2022). Tumor-associated macrophages promote epithelial\u2013mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/\u03b2-catenin signaling. Cell Communication and Signaling, 20, 92.","journal-title":"Cell Communication and Signaling"},{"key":"11198_CR45","doi-asserted-by":"publisher","first-page":"7661","DOI":"10.1038\/s41467-023-43548-w","volume":"14","author":"S Shang","year":"2023","unstructured":"Shang, S., et al. (2023). ID1 expressing macrophages support cancer cell stemness and limit CD8+\u2009T cell infiltration in colorectal cancer. Nature Communications, 14, 7661.","journal-title":"Nature Communications"},{"key":"11198_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jare.2024.01.016","volume":"67","author":"G Li","year":"2025","unstructured":"Li, G., Gao, J., Ding, P., & Gao, Y. (2025). The role of endothelial cell\u2013pericyte interactions in vascularization and diseases. Journal of Advanced Research, 67, 269\u2013288.","journal-title":"Journal of Advanced Research"},{"key":"11198_CR47","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.ajpath.2013.01.019","volume":"182","author":"T Matsui","year":"2013","unstructured":"Matsui, T., Kinugasa, Y., Tahara, H., Kanakura, Y., & Takakura, N. (2013). Possible role of mural cell\u2013covered mature blood vessels in inducing drug resistance in cancer-initiating cells. The American Journal of Pathology, 182, 1790\u20131799.","journal-title":"The American Journal of Pathology"},{"key":"11198_CR48","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ccell.2023.07.012","volume":"41","author":"Q Huang","year":"2023","unstructured":"Huang, Q., et al. (2023). CD44+\u2009lung cancer stem cell-derived pericyte-like cells cause brain metastases through GPR124-enhanced trans-endothelial migration. Cancer Cell, 41, 1621\u20131636.e1628.","journal-title":"Cancer Cell"},{"key":"11198_CR49","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1016\/S1556-0864(16)30283-0","volume":"11","author":"CC Cheng","year":"2016","unstructured":"Cheng, C. C., & Su, J. L. (2016). 173P: Vascular endothelial growth factor-C promotes EGFR-TKIs resistance and cancer stemness via SLUG of non-small cell lung cancer. Journal of Thoracic Oncology, 11, S132\u2013S133.","journal-title":"Journal of Thoracic Oncology"},{"key":"11198_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s43018-023-00658-0","volume":"5","author":"L Zhao","year":"2024","unstructured":"Zhao, L., et al. (2024). Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism. Nature Cancer, 5, 147\u2013166.","journal-title":"Nature Cancer"},{"key":"11198_CR51","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/1878-0261.12071","volume":"11","author":"R Wang","year":"2017","unstructured":"Wang, R., et al. (2017). Endothelial cells activate the cancer stem cell-associated NANOGP8 pathway in colorectal cancer cells in a paracrine fashion. Molecular Oncology, 11, 1023\u20131034.","journal-title":"Molecular Oncology"},{"key":"11198_CR52","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/stem.3050","volume":"37","author":"RA Sabol","year":"2019","unstructured":"Sabol, R. A., Giacomelli, P., Beighley, A., & Bunnell, B. A. (2019). Adipose stem cells and cancer: Concise review. Stem Cells, 37, 1261\u20131266.","journal-title":"Stem Cells"},{"key":"11198_CR53","first-page":"1","volume":"21","author":"F Wang","year":"2019","unstructured":"Wang, F., et al. (2019). BMSC-derived leptin and IGFBP2 promote erlotinib resistance in lung adenocarcinoma cells through IGF-1R activation in hypoxic environment. Cancer Biology & Therapy, 21, 61\u201371.","journal-title":"Cancer Biology & Therapy"},{"key":"11198_CR54","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/1440-1681.13294","volume":"47","author":"X Tao","year":"2020","unstructured":"Tao, X., et al. (2020). Puerarin 6\u2033-O-xyloside suppresses growth, self-renewal and invasion of lung cancer stem-like cells derived from A549 cells via regulating Akt\/c-Myc signalling. Clinical and Experimental Pharmacology and Physiology, 47, 1311\u20131319.","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"11198_CR55","doi-asserted-by":"publisher","first-page":"109211","DOI":"10.1016\/j.jnutbio.2022.109211","volume":"112","author":"C Xie","year":"2023","unstructured":"Xie, C., et al. (2023). Resveratrol suppresses lung cancer by targeting cancer stem-like cells and regulating tumor microenvironment. The Journal of Nutritional Biochemistry, 112, 109211.","journal-title":"The Journal of Nutritional Biochemistry"},{"key":"11198_CR56","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.3892\/ijmm.2020.4758","volume":"46","author":"P Jiang","year":"2020","unstructured":"Jiang, P., et al. (2020). Epigallocatechin\u20133\u2013gallate inhibits self\u2013renewal ability of lung cancer stem\u2013like cells through inhibition of CLOCK. International Journal Of Molecular Medicine, 46, 2216\u20132224.","journal-title":"International Journal Of Molecular Medicine"},{"key":"11198_CR57","doi-asserted-by":"publisher","first-page":"8623","DOI":"10.1002\/jcb.27117","volume":"119","author":"P Jiang","year":"2018","unstructured":"Jiang, P., et al. (2018). Epigallocatechin-3-gallate inhibited cancer stem cell\u2013like properties by targeting hsa-mir-485-5p\/RXR\u03b1 in lung cancer. Journal of Cellular Biochemistry, 119, 8623\u20138635.","journal-title":"Journal of Cellular Biochemistry"},{"key":"11198_CR58","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jgr.2020.02.005","volume":"45","author":"H Kim","year":"2021","unstructured":"Kim, H., et al. (2021). Ginsenosides Rk1 and Rg5 inhibit transforming growth factor-\u03b21-induced epithelial-mesenchymal transition and suppress migration, invasion, anoikis resistance, and development of stem-like features in lung cancer. Journal of Ginseng Research, 45, 134\u2013148.","journal-title":"Journal of Ginseng Research"},{"key":"11198_CR59","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.12659\/MSM.914219","volume":"25","author":"YM Zhang","year":"2019","unstructured":"Zhang, Y. M., et al. (2019)The effects of astragalus polysaccharide on bone marrow-derived mesenchymal stem cell proliferation and morphology induced by A549 lung cancer cells. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 25, 4110\u20134121.","journal-title":"in Med Sci Monit"},{"key":"11198_CR60","doi-asserted-by":"publisher","first-page":"9667","DOI":"10.7150\/thno.62676","volume":"11","author":"PJ Lee","year":"2021","unstructured":"Lee, P. J., et al. (2021). Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts. Theranostics, 11, 9667\u20139686.","journal-title":"Theranostics"},{"key":"11198_CR61","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020). Metabolic reprogramming and cancer progression. Science, 368, eaaw5473.","journal-title":"Science"},{"key":"11198_CR62","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/bmj.2.3475.284","volume":"2","author":"WB Bell","year":"1927","unstructured":"Bell, W. B. (1927). The metabolism of tumours. British Medical Journal, 2, 284.","journal-title":"British Medical Journal"},{"key":"11198_CR63","doi-asserted-by":"publisher","first-page":"108690","DOI":"10.1016\/j.biopha.2019.108690","volume":"112","author":"Z Ghanbari Movahed","year":"2019","unstructured":"Ghanbari Movahed, Z., Rastegari-Pouyani, M., Mohammadi, M., & Mansouri, K. (2019). Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell? Biomedicine & Pharmacotherapy, 112, 108690.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"11198_CR64","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1126\/science.122.3168.501","volume":"122","author":"H Eagle","year":"1955","unstructured":"Eagle, H. (1955). Nutrition needs of mammalian cells in tissue culture. Science, 122, 501\u2013504.","journal-title":"Science"},{"key":"11198_CR65","doi-asserted-by":"crossref","unstructured":"Wei, Z., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021). Metabolism of amino acids in cancer. Frontiers in Cell and Developmental Biology, 8, 603837.","DOI":"10.3389\/fcell.2020.603837"},{"key":"11198_CR66","doi-asserted-by":"publisher","first-page":"e20201606","DOI":"10.1084\/jem.20201606","volume":"218","author":"X Bian","year":"2020","unstructured":"Bian, X., et al. (2020). Lipid metabolism and cancer. Journal of Experimental Medicine, 218, e20201606.","journal-title":"Journal of Experimental Medicine"},{"key":"11198_CR67","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nrc.2016.85","volume":"16","author":"LB Sullivan","year":"2016","unstructured":"Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016). Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. Nature Reviews Cancer, 16, 680\u2013693.","journal-title":"Nature Reviews Cancer"},{"key":"11198_CR68","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward, P. S., & Thompson, C. B. (2012). Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate. Cancer Cell, 21, 297\u2013308","journal-title":"Cancer Cell"},{"key":"11198_CR69","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/s41590-020-0783-5","volume":"21","author":"P Li","year":"2020","unstructured":"Li, P., et al. (2020). Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis. Nature Immunology, 21, 1444\u20131455.","journal-title":"Nature Immunology"},{"key":"11198_CR70","doi-asserted-by":"crossref","unstructured":"Zhu, M., et al. (2022). Clinical significance and immunometabolism landscapes of a novel recurrence-associated lipid metabolism signature In early-stage lung adenocarcinoma: A comprehensive analysis. Frontiers in Immunology, 13, 783495.","DOI":"10.3389\/fimmu.2022.783495"},{"key":"11198_CR71","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3892\/ol.2022.13407","volume":"24","author":"X Li","year":"2022","unstructured":"Li, X., Liu, M., Liu, H., & Chen, J. (2022). Tumor metabolic reprogramming in lung cancer progression (Review). Oncology Letters, 24, 287.","journal-title":"Oncol Lett"},{"key":"11198_CR72","doi-asserted-by":"crossref","unstructured":"Huang, Y., et al. (2019)). Prognostic effects of glycometabolism changes in lung adenocarcinoma: a prospective observational study. Translational Lung Cancer Research, 8, 808\u2013819.","DOI":"10.21037\/tlcr.2019.10.18"},{"key":"11198_CR73","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.drudis.2016.12.003","volume":"22","author":"MJ Lukey","year":"2017","unstructured":"Lukey, M. J., Katt, W. P., & Cerione, R. A. (2017). Targeting amino acid metabolism for cancer therapy. Drug Discovery Today, 22, 796\u2013804.","journal-title":"Drug Discovery Today"},{"key":"11198_CR74","first-page":"2022","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu, J., et al. (2022). Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma. Frontiers in Immunology, 13, 960738.","journal-title":"Frontiers in Immunology"},{"key":"11198_CR75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12929-019-0593-y","volume":"27","author":"HS Hsu","year":"2020","unstructured":"Hsu, H. S., et al. (2020). Involvement of collagen XVII in pluripotency gene expression and metabolic reprogramming of lung cancer stem cells. Journal of Biomedical Science, 27, 5.","journal-title":"Journal of Biomedical Science"},{"key":"11198_CR76","doi-asserted-by":"publisher","first-page":"11798","DOI":"10.1038\/ncomms11798","volume":"7","author":"CC Liu","year":"2016","unstructured":"Liu, C. C., et al. (2016). Suspension survival mediated by PP2A-STAT3-Col XVII determines tumour initiation and metastasis in cancer stem cells. Nature Communications, 7, 11798.","journal-title":"Nature Communications"},{"key":"11198_CR77","doi-asserted-by":"publisher","first-page":"128412","DOI":"10.1016\/j.ijbiomac.2023.128412","volume":"256","author":"YH Zhang","year":"2024","unstructured":"Zhang, Y. H., et al. (2024). A novel lung cancer stem cell extracellular vesicles lncRNA ROLLCSC modulate non-stemness cancer cell plasticity through miR-5623-3p and miR-217-5p targeting lipid metabolism. International Journal of Biological Macromolecules, 256, 128412.","journal-title":"International Journal of Biological Macromolecules"},{"key":"11198_CR78","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1158\/0008-5472.CAN-21-0567","volume":"81","author":"X Wang","year":"2021","unstructured":"Wang, X., et al. (2021). Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11. Cancer Research, 81, 5217\u20135229.","journal-title":"Cancer Research"},{"key":"11198_CR79","doi-asserted-by":"publisher","first-page":"145666","DOI":"10.1016\/j.gene.2021.145666","volume":"788","author":"F Yang","year":"2021","unstructured":"Yang, F., et al. (2021). Nano-realgar suppresses lung cancer stem cell growth by repressing metabolic reprogramming. Gene, 788, 145666.","journal-title":"Gene"},{"key":"11198_CR80","doi-asserted-by":"crossref","unstructured":"Zhang, S., et al. (2021). A Metabolic Profiling Study of Realgar-Induced Acute Kidney Injury in Mice. Frontiers in Pharmacology, 12, 706249.","DOI":"10.3389\/fphar.2021.706249"},{"key":"11198_CR81","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00018-022-04453-5","volume":"79","author":"H Deng","year":"2022","unstructured":"Deng, H., et al. (2022). Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage. Cellular and Molecular Life Sciences, 79, 445.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"11198_CR82","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/biof.2031","volume":"50","author":"Z Guo","year":"2024","unstructured":"Guo, Z., et al. (2024). Natural product fargesin interferes with H3 histone lactylation via targeting PKM2 to inhibit non-small cell lung cancer tumorigenesis. Biofactors, 50, 592\u2013607.","journal-title":"Biofactors"},{"key":"11198_CR83","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000534547","volume":"109","author":"W Tang","year":"2023","unstructured":"Tang, W., Tang, H., Xu, S., Yu, H., & Chen, Z. (2023). Transcription factor MITF inhibits the transcription of CPT1B to regulate fatty acid \u03b2-oxidation and thus affects stemness in lung adenocarcinoma cells. Pharmacology, 109, 52\u201364.","journal-title":"Pharmacology"},{"key":"11198_CR84","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41586-023-06585-5","volume":"622","author":"X Li","year":"2023","unstructured":"Li, X., et al. (2023). Inhibition of fatty acid oxidation enables heart regeneration in adult mice. Nature, 622, 619\u2013626.","journal-title":"Nature"},{"key":"11198_CR85","doi-asserted-by":"publisher","first-page":"10955","DOI":"10.3390\/ijms222010955","volume":"22","author":"YH Liu","year":"2021","unstructured":"Liu, Y. H., et al. (2021). L-type amino acid transporter 1 regulates cancer stemness and the expression of programmed cell death 1 ligand 1 in lung cancer cells. International Journal of Molecular Sciences, 22, 10955.","journal-title":"in International Journal of Molecular Sciences"},{"key":"11198_CR86","doi-asserted-by":"publisher","first-page":"107964","DOI":"10.1016\/j.pharmthera.2021.107964","volume":"230","author":"Y Kanai","year":"2022","unstructured":"Kanai, Y. (2022). Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacology & Therapeutics, 230, 107964.","journal-title":"Pharmacology & Therapeutics"},{"key":"11198_CR87","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","volume":"593","author":"BI Reinfeld","year":"2021","unstructured":"Reinfeld, B. I., et al. (2021). Cell-programmed nutrient partitioning in the tumour microenvironment. Nature, 593, 282\u2013288.","journal-title":"Nature"},{"key":"11198_CR88","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/bmj.1.5023.841","volume":"1","author":"M Burnet","year":"1957","unstructured":"Burnet, M. (1957). Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. British Medical Journal, 1, 841\u2013847.","journal-title":"British medical journal"},{"key":"11198_CR89","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/bmj.1.5022.779","volume":"1","author":"M Burnet","year":"1957","unstructured":"Burnet, M. (1957). Cancer; a biological approach. I. The processes of control. British Medical Journal, 1, 779\u2013786.","journal-title":"British medical journal"},{"key":"11198_CR90","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002). Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunology, 3, 991\u2013998.","journal-title":"Nature Immunology"},{"key":"11198_CR91","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011). Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and p romotion. Science, 331, 1565\u20131570.","journal-title":"Science"},{"key":"11198_CR92","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144, 646\u2013674","journal-title":"Cell"},{"key":"11198_CR93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","volume":"39","author":"GT Motz","year":"2013","unstructured":"Motz, G. T., & Coukos, G. (2013). Deciphering and reversing tumor immune suppression. Immunity, 39, 61\u201373.","journal-title":"Immunity"},{"key":"11198_CR94","doi-asserted-by":"crossref","unstructured":"Xu, C., et al. (2022). SIRP\u03b3-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signaling. The Journal of Clinical Investigation, 132, e141797.","DOI":"10.1172\/JCI141797"},{"key":"11198_CR95","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00262-021-02998-1","volume":"71","author":"MA Kursunel","year":"2022","unstructured":"Kursunel, M. A., et al. (2022). Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes. Cancer Immunology Immunotherapy, 71, 445\u2013459.","journal-title":"Cancer Immunology Immunotherapy"},{"key":"11198_CR96","doi-asserted-by":"publisher","first-page":"24153","DOI":"10.1021\/jacs.3c08032","volume":"145","author":"Q Feng","year":"2023","unstructured":"Feng, Q., Fang, W., Guo, Y., Hu, P., & Shi, J. (2023). Nebulized therapy of early orthotopic lung cancer by iron-based nanoparticles: Macrophage-regulated ferroptosis of cancer stem cells. Journal of the American Chemical Society, 145, 24153\u201324165.","journal-title":"Journal of the American Chemical Society"},{"key":"11198_CR97","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma, L., et al. (2024). Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer. Signal Transduction and Targeted Therapy, 9, 64.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"11198_CR98","doi-asserted-by":"crossref","unstructured":"Jie, Y., et al. (2021). PTK7-targeting CAR T-cells for the treatment of lung cancer and other malignancies. Frontiers in Immunology, 12, 665970.","DOI":"10.3389\/fimmu.2021.665970"},{"key":"11198_CR99","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","volume":"3","author":"MJ Lin","year":"2022","unstructured":"Lin, M. J., et al. (2022). Cancer vaccines: the next immunotherapy frontier. Nature Cancer, 3, 911\u2013926.","journal-title":"Nature Cancer"},{"key":"11198_CR100","doi-asserted-by":"publisher","first-page":"115699","DOI":"10.1016\/j.taap.2021.115699","volume":"429","author":"NE El-Ashmawy","year":"2021","unstructured":"El-Ashmawy, N. E., Salem, M. L., El-Fattah, A., E.E., & Khedr, E. G. (2021). Targeting CD166\u2009+\u2009lung cancer stem cells: Molecular study using murine dendritic cell vaccine. Toxicology and Applied Pharmacology, 429, 115699.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"11198_CR101","doi-asserted-by":"crossref","unstructured":"Ge, Z., & Ding, S. Z. (2020). The crosstalk between tumor-associated macrophages (TAMs) and tumor cells and the corresponding targeted therapy. Frontiers in Oncology, 10, 590941.","DOI":"10.3389\/fonc.2020.590941"},{"key":"11198_CR102","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A., et al. (2016). LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metabolism, 24, 657\u2013671.","journal-title":"Cell Metabolism"},{"key":"11198_CR103","first-page":"395","volume":"63","author":"AS Thakor","year":"2013","unstructured":"Thakor, A. S., & Gambhir, S. S. (2013). Nanooncology: the future of cancer diagnosis and therapy. CA: a cancer journal for clinicians, 63, 395\u2013418.","journal-title":"CA: a cancer journal for clinicians"},{"key":"11198_CR104","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","volume":"160","author":"L Gao","year":"2012","unstructured":"Gao, L., et al. (2012). Drug nanocrystals: In vivo performances. Journal of Controlled Release, 160, 418\u2013430.","journal-title":"Journal of Controlled Release"},{"key":"11198_CR105","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2217\/nnm.15.166","volume":"11","author":"H Wang","year":"2016","unstructured":"Wang, H., Yu, J., Lu, X., & He, X. (2016). Nanoparticle systems reduce systemic toxicity in cancer treatment. Nanomedicine: The Official Journal Of The American Academy Of Nanomedicine, 11, 103\u2013106.","journal-title":"Nanomedicine: The Official Journal Of The American Academy Of Nanomedicine"},{"key":"11198_CR106","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1021\/acsabm.2c00002","volume":"5","author":"MI Khan","year":"2022","unstructured":"Khan, M. I., et al. (2022). Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review. ACS Applied Bio Materials, 5, 971\u20131012.","journal-title":"ACS Applied Bio Materials"},{"key":"11198_CR107","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra, J. K., et al. (2018). Nano based drug delivery systems: recent developments and future prospects. Journal of Nanobiotechnology, 16, 71.","journal-title":"Journal of Nanobiotechnology"},{"key":"11198_CR108","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1002\/smll.201600635","volume":"12","author":"Y Ma","year":"2016","unstructured":"Ma, Y., Huang, J., Song, S., Chen, H., & Zhang, Z. (2016). Cancer-targeted nanotheranostics: Recent advances and perspectives. Small, 12, 4936\u20134954.","journal-title":"Small (Weinheim An Der Bergstrasse, Germany)"},{"key":"11198_CR109","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1124\/mol.118.114447","volume":"95","author":"N Petpiroon","year":"2019","unstructured":"Petpiroon, N., et al. (2019). Ti0.8O2 nanosheets inhibit lung cancer stem cells by inducing production of superoxide anion. Molecular Pharmacology, 95, 418\u2013432.","journal-title":"Molecular Pharmacology"},{"key":"11198_CR110","doi-asserted-by":"crossref","unstructured":"Tulbah, A. (2022). Inhaled atorvastatin nanoparticles for lung cancer. Current Drug Delivery,  19, 1073-1082.","DOI":"10.2174\/1567201819666220426091500"},{"key":"11198_CR111","doi-asserted-by":"publisher","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","volume":"176","author":"DE Large","year":"2021","unstructured":"Large, D. E., Abdelmessih, R. G., Fink, E. A., & Auguste, D. T. (2021). Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Advanced Drug Delivery Reviews, 176, 113851.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"11198_CR112","doi-asserted-by":"publisher","first-page":"e3460","DOI":"10.1002\/btpr.3460","volume":"40","author":"S Nie","year":"2024","unstructured":"Nie, S., et al. (2024). CD133 ligand-enhanced etoposide-liposome complex for targeted killing of lung cancer cells. Biotechnology Progress, 40, e3460.","journal-title":"Biotechnology Progress"},{"key":"11198_CR113","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fchem.2022.920123","volume":"10","author":"J Ding","year":"2022","unstructured":"Ding, J., et al. (2022). Fluorescence detection of cancer stem cell markers using a sensitive nano-aptamer sensor. Frontiers in Chemistry, 10, 920123.","journal-title":"Frontiers in Chemistry"},{"key":"11198_CR114","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1080\/17435889.2024.2422804","volume":"19","author":"D Leng","year":"2024","unstructured":"Leng, D., et al. (2024). CD133-targeted afatinib nanomicelles for enhanced lung cancer theranostics. Nanomedicine: The Official Journal Of The American Academy Of Nanomedicine, 19, 2605\u20132617.","journal-title":"Nanomedicine: The Official Journal Of The American Academy Of Nanomedicine"},{"key":"11198_CR115","doi-asserted-by":"publisher","first-page":"216673","DOI":"10.1016\/j.ccr.2025.216673","volume":"535","author":"Y Chen","year":"2025","unstructured":"Chen, Y., Guo, Z., Li, J., Wang, K., & Huang, J. (2025). Smart nucleic acid nanodrug delivery system for precision therapeutics. Coordination Chemistry Reviews, 535, 216673.","journal-title":"Coordination Chemistry Reviews"},{"key":"11198_CR116","doi-asserted-by":"publisher","first-page":"16329","DOI":"10.1021\/acsami.2c19029","volume":"15","author":"Y Jia","year":"2023","unstructured":"Jia, Y., et al. (2023). Tumor Microenvironment-responsive nanoherb delivery system for synergistically inhibition of cancer stem cells. ACS Applied Materials & Interfaces, 15, 16329\u201316342.","journal-title":"ACS Applied Materials & Interfaces"},{"key":"11198_CR117","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1039\/C9NR07947E","volume":"12","author":"W Cao","year":"2020","unstructured":"Cao, W., et al. (2020). MnO2@Ce6-loaded mesenchymal stem cells as an oxygen-laden guided-missile for the enhanced photodynamic therapy on lung cancer. Nanoscale, 12, 3090\u20133102.","journal-title":"Nanoscale"},{"key":"11198_CR118","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jconrel.2020.02.021","volume":"321","author":"R Iyer","year":"2020","unstructured":"Iyer, R., et al. (2020). Glutathione-responsive biodegradable polyurethane nanoparticles for lung cancer treatment. Journal of Controlled Release, 321, 363\u2013371.","journal-title":"Journal of Controlled Release"},{"key":"11198_CR119","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejpb.2016.10.014","volume":"109","author":"WT Huang","year":"2016","unstructured":"Huang, W. T., Larsson, M., Lee, Y. C., Liu, D. M., & Chiou, G. Y. (2016). Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells. European Journal of Pharmaceutics and Biopharmaceutics, 109, 165\u2013173.","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"11198_CR120","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.2147\/DDDT.S386100","volume":"16","author":"M Du","year":"2022","unstructured":"Du, M., & Yin, J. (2022), Dual-drug, & nanosystem: Etoposide prodrug and cisplatin coloaded nanostructured lipid carriers for lung cancer therapy. Drug Design, Development and Therapy, 16, 4139\u20134149.","journal-title":"Drug design development and therapy"},{"key":"11198_CR121","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/biom14121651","volume":"14","author":"K Butcher","year":"2024","unstructured":"Butcher, K., et al. (2024). PLGA-nano-encapsulated disulfiram inhibits cancer stem cells and targets non-small cell lung cancer in vitro and in vivo. Biomolecules, 14, 1651.","journal-title":"in Biomolecules"},{"key":"11198_CR122","doi-asserted-by":"publisher","first-page":"113904","DOI":"10.1016\/j.yexcr.2023.113904","volume":"435","author":"G Abbas","year":"2024","unstructured":"Abbas, G., et al. (2024). Antitumor efficacy of synthesized Ag\u2013Au nanocomposite loaded with PEG and ascorbic acid in human lung cancer stem cells. Experimental Cell Research, 435, 113904.","journal-title":"Experimental Cell Research"},{"key":"11198_CR123","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.3390\/ijms21113742","volume":"21","author":"A Crous","year":"2020","unstructured":"Crous, A., & Abrahamse, H. (2020). Effective gold nanoparticle-antibody-mediated drug delivery for photodynamic therapy of lung cancer stem cells. International Journal of Molecular Sciences, 21, 3742.","journal-title":"International Journal of Molecular Sciences"},{"key":"11198_CR124","doi-asserted-by":"publisher","first-page":"2404219","DOI":"10.1002\/smll.202404219","volume":"20","author":"X Wang","year":"2024","unstructured":"Wang, X., Tang, Y., Yang, L., Wang, X., & Qi, Z. (2024). Sequential responsive multifunctional nanomicelle effectuates collective elimination of breast cancer and cancer stem cells. Small, 20, 2404219.","journal-title":"Small (Weinheim An Der Bergstrasse, Germany)"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11198-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:04:06Z","timestamp":1788768246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11198-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":124,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11198"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11198-2","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}